Takuya Miyazaki
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Hexa- and hepta-coordinate cobalt(II) complexes bearing bis(2-pyridylmethyl)ether.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: September 04, 2026
Fertility preservation and treatment outcomes in female patients with chronic-phase chronic myeloid leukemia: a single-institution experience
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 29, 2026
Treatment outcomes of adult B-cell ALL with post-transplant relapse in the era of immunotherapeutic agents.
Journal: Transplantation and cellular therapy
Published: March 24, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
Journal: Blood cancer journal
Published: February 14, 2026
Personalized multivariable clinical prognostic model for patients with acute myeloid leukemia receiving intensive chemotherapy.
Journal: International journal of hematology
Published: December 25, 2025
T-cell help is a limiting factor for rare anti-influenza memory B cells to re-enter germinal centers and generate potent broadly neutralizing antibodies.
Journal: International immunology
Published: November 21, 2025
Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.
Journal: Annals of hematology
Published: September 29, 2025
Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: September 19, 2025
Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: September 05, 2025
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: April 10, 2025
Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma.
Journal: Internal medicine (Tokyo, Japan)
Published: March 16, 2025
Last Updated: 09/26/2026